ESR1 and invasive breast carcinoma: In invasive breast cancer of no special type, high STING expression was linked to estrogen receptor (ER) and progesterone receptor (PR) expression (p < 0.0001 each), non-triple-negative status (p = 0.0028), and poor overall survival (p = 0.0196; Figure 3).